Yerkes Center, OSHA Settle Death Case

In early December, Emory University in Atlanta agreed to pay $66,400 in fines and change its operating procedures in response to the December 1997 death of Elizabeth Griffin, a 22-year-old worker at its Yerkes Regional Primate Center. Griffin contracted herpes B virus, common in Old World macaques, when she was hit in the eye with fecal material, urine, or saliva while transferring a rhesus monkey to a cage.1 Though rare in humans, B virus is often lethal unless treated early with antiviral dru

Written byBarry Palevitz
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

In early December, Emory University in Atlanta agreed to pay $66,400 in fines and change its operating procedures in response to the December 1997 death of Elizabeth Griffin, a 22-year-old worker at its Yerkes Regional Primate Center. Griffin contracted herpes B virus, common in Old World macaques, when she was hit in the eye with fecal material, urine, or saliva while transferring a rhesus monkey to a cage.1 Though rare in humans, B virus is often lethal unless treated early with antiviral drugs such as acyclovir. It was the only job-related death in Yerkes' history.

"We feel that prolonging the dispute further... would serve little purpose" --Thomas Insel In its original complaint last April, the Occupational Safety and Health Administration (OSHA) asked for more than $100,000 in fines for a number of infractions including a "willful safety and health violation." OSHA claimed that Yerkes didn't provide Griffin with "appropriate eye ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies